Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease

Journal of Hypertension, Supplement

Volumn 15, Issue 2, 1997, Pages

  Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Diabetic nephropathy; Glomerulosclerosis; Proteinuria; Renal failure

Indexed keywords

ANGIOTENSIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; DRUG EFFICACY; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALCIUM CHANNEL BLOCKERS; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY FAILURE; RATS;

EID: 0030944201     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Brenner BM, Meyer TW, Hosteller TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in ageing, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307:652-665.
2. Hostetter TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995, 57:263-278.
3. US Renal Data System: USRDS 1996 Annual Report. Bethesda: National Institutes of Health; 1996.
4. Raine AE: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 1993, 36:99-104.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD and the Collaborative Study Group: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.